(2Z)-N-benzyl-2-[3-(4-bromophenyl)-5-[(3-bromophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide
Formula:C26H19N3O2Br2S
Mutagenic:none
Tumorigenic:none
Reproductive Effective:high
(2Z)-N-benzyl-2-[3-(4-bromophenyl)-5-[(3-bromophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide is not a drug-like molecule.
| MolName | (2Z)-N-benzyl-2-[3-(4-bromophenyl)-5-[(3-bromophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide |
| MolecularFormula | C26H19N3O2Br2S |
| Smiles | N#C/C(/C(NCc1ccccc1)=O)=C(\N1c(cc2)ccc2Br)/SC(Cc2cccc(Br)c2)C1=O |
| InChI | InChI=1S/C26H19Br2N3O2S/c27-19-9-11-21(12-10-19)31-25(33)23(14-18-7-4-8-20(28)13-18)34-26(31)22(15-29)24(32)30-16-17-5-2-1-3-6-17/h1-13,23H,14,16H2,(H,30,32)/t23-/m0/s1 |
| InChIK | BODDXCYPGABUOO-QHCPKHFHSA-N |
| TotalMolweight | 597.33 |
| Molweight | 597.33 |
| MonoisotopicMass | 594.956469 |
| CLogP | 5.8749 |
| CLogS | -7.298 |
| H Acceptors | 5 |
| H Donors | 1 |
| TotalSurfaceArea | 375.94 |
| Relative PSA | 0.19189 |
| PolarSurfaceArea | 98.5 |
| Druglikeness | -0.22189 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB |
| Shape Index | 0.47059 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 18 |
| Sp3Atoms | 4 |
| Symmetricatoms | 4 |
| Amides | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (2Z)-N-benzyl-2-[3-(4-bromophenyl)-5-[(3-bromophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide | 2 - (2Z)-N-benzyl-2-[3-(4-bromophenyl)-5-[(3-bromophenyl)methyl]-4-oxo-1,3-thiazolidin-2-ylidene]-2-cyanoacetamide
Spacefill |
Wire |
Ball & Stick |
Iso-vdw |
Opaque |
Dot Surface |
Mep |
Translucent |
Spin |
Label On |
Off